Nac Ratiopharm (Acetylcysteine)

Acetylcysteine works by breaking disulfide bonds in the protein structure of mucus, which reduces its viscosity and elasticity. This depolymerisation makes the secretions less sticky and easier to expectorate. Additionally, it provides cysteine for the synthesis of glutathione, an important antioxidant that protects airway cells from oxidative damage.

The dosage of Nac Ratiopharm is determined by the prescribing clinician based on the patient’s age, weight, renal function and the specific respiratory condition being treated. The prescriber will select the appropriate strength, frequency and duration according to current clinical guidelines and individual therapeutic response.

Safety data for acetylcysteine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional after a careful risk‑benefit assessment.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other mucolytic agents such as carbocisteine or bromhexine, acetylcysteine has a dual action: it directly reduces mucus viscosity and also replenishes intracellular glutathione. This antioxidant property may offer additional protection against oxidative stress in the lungs, although clinical choice depends on physician preference, patient tolerance and specific guideline recommendations.

Nac Ratiopharm should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use to maintain stability and potency.

The medication is formulated for oral administration. Patients should swallow the tablet or capsule whole with a glass of water, unless otherwise directed by a healthcare professional. It is usually taken with or without food, depending on the prescriber’s instructions and patient tolerance.

The most serious adverse reactions include anaphylaxis, severe bronchospasm, Stevens‑Johnson syndrome and rare cases of hepatotoxicity. If any signs of a severe allergic reaction, breathing difficulty, skin blistering or abnormal liver function tests occur, immediate medical attention is required and the drug should be discontinued.

Nac Ratiopharm is contraindicated in patients with known hypersensitivity to acetylcysteine or any of its excipients. Caution is also advised for individuals with severe asthma, active peptic ulcer disease, or G6PD deficiency, as they may be at higher risk for bronchospasm or hemolysis, respectively.